Click the recall below to see the full story:
_______________________________________________________________________________________________________
WASHINGTON, DC – The U.S. Consumer Product Safety Commission and Health Canada, in cooperation with the firm named below, today announced a voluntary recall of the following products. Consumers should stop using recalled products immediately unless otherwise instructed.
Consumer Contact: For additional information, contact Tiny Love toll-free at (888) 791-8166 between 8 a.m. and 5 p.m. ET Monday through Friday, or visit the firm’s Web site at www.tinylove.com.
Note: Health Canada’s press release is available at http://cpsr-rspc.hc-sc.gc.ca/PR-RP/recall-retrait-eng.jsp?re_id=974
To see this recall on CPSC’s web site, including pictures of the recalled products, please go to: http://www.cpsc.gov/cpscpub/prerel/prhtml10/10136.html
_______________________________________________________________________________________________________
WASHINGTON, DC – The U.S. Consumer Product Safety Commission and Health Canada, in cooperation with the firm named below, today announced a voluntary recall of the following products. Consumers should stop using recalled products immediately unless otherwise instructed.
Consumer Contact: For additional information, contact Britax toll-free at (888) 427-4829 between 8 a.m. and 5 p.m. ET Monday through Friday, or visit the firm’s website at www.BlinkRecall.com.
Note: Health Canada’s press release is available at http://cpsr-rspc.hc-sc.gc.ca/PR-RP/recall-retrait-eng.jsp?re_id=971
To see this recall on CPSC’s web site, including a picture of the recalled product, please go to: http://www.cpsc.gov/cpscpub/prerel/prhtml10/10137.html
_______________________________________________________________________________________________________
WASHINGTON, DC – The U.S. Consumer Product Safety Commission and Health Canada, in cooperation with the firm named below, today announced a voluntary recall of the following products. Consumers should stop using recalled products immediately unless otherwise instructed.
Consumer Contact: For additional information, contact Manhattan Group at (800) 541-1345 between 8 a.m. and 5 p.m. CT Monday through Friday or visit the firm’s Web site at www.manhattantoy.com.
Note: Health Canada’s press release is available at http://cpsr-rspc.hc-sc.gc.ca/PR-RP/recall-retrait-eng.jsp?re_id=973
To see this recall on CPSC’s web site, including pictures of the recalled products, please go to: http://www.cpsc.gov/cpscpub/prerel/prhtml10/10138.html
Dear Friends of First Candle,
It is with great pride and excitement that we share with you today news of a new study out of the SIDS Center of Excellence at Children’s Hospital Boston, led by Harvard researcher Dr. Hannah Kinney, regarding another breakthrough in SIDS research!
The findings from the study indicate we are closing in on a defect in the brainstem related to serotonin as a likely cause for SIDS. This recent study built on the research team’s 2006 study that identified potential problems with serotonin and serotonin receptor bindings in the brainstems of babies who die of SIDS. The results of the study are based on a comparison of brainstem samples from infants dying of SIDS to brainstems of infants dying from other, known causes. The findings will be published in the February 3 issue of The Journal of the American Medical Association.
The results are compelling and send a strong message to parents on the importance of good prenatal care and safe sleep in protecting babies from SIDS, the leading cause of death for babies one month to one year of age.
For those that would like further information, please refer to First Candle’s press release, the press release out of Harvard and the full text of the article.
We would also like to recognize Dr. Henry Krous of the SIDS/SUDC research project at Rady Children’s Hospital-San Diego. Critical to Dr. Kinney’s work is the availability of tissue samples. Dr. Krous’ is the only project currently collecting tissue samples for research purposes .
First Candle has been nationally recognized as key supporters of these projects throughout the past 20 years, and we would like to thank you, our many supporters, for the role you have played in this success; we couldn’t have done it without each and every one of you.
We would like to close with a call to action.
It is critical that we continue to move this research forward to find out what causes this defect, identify babies at risk and develop preventive treatments for the serotonin deficit.
Thank you in advance for your ongoing support of our efforts – in the belief that every baby should live.
Warm regards,
The board and staff of First Candle
© Copyright 2010 First Candle - Site Designed by The Ocean Agency - Chicago Web Design